MEDASSIST PROGRAM

Frequently Asked Questions

    MedAssist staff will review your complete application and assign a grant value based on three (3) factors.

    • Total Annual Household Gross Income (Percent of Federal Poverty Level (FPL))
    • ­Estimate total household out-of-pocket healthcare expenses from the previous calendar year (January 2020 – December 2020)
    • Medication Category (Insulin, Asthma Inhaler, Epinephrine Auto-injector)
    • You will be approved to receive monthly grant payments for the duration of time you are covered by that fill.
    • For example, a fill for a 90 days supply will approve you to receive monthly grant distribution for three (3) months.

    Yes, please see details by visiting the “Appeals” page on the left sidebar.

    Regardless of when your application was approved, your grant will be valid through June 30, 2022. 

    Yes, you will be required to re-apply for the program for the next year’s cycle (July 2022 – June 2023). The application for the next year’s cycle will open on June 1, 2022.  

    Yes, health insurance is not a program eligibility requirement.

    You have a thirty (30) calendar days grace period to submit proof of a prescription fill or Epinephrine Attestation Form. For example to receive grant disbursement for the month of January, you will have thirty (30) calendar days from last day of January to upload your documents. Once this grace period has passed, you will not be able to receive a grant payment for that month.

    After your application is approved, you will be given instruction on how to provide the banking information.

    • Insulin glulisine (Apidra®)
    • Insulin aspart (Novolog®)
    • Insulin lispro (Humalog®)
    • Regular insulin (Novolin R, Humulin R)
    • NPH insulin (Novolin N, Humulin N)
    • Insulin detemir (Levemir®)
    • Insulin glargine U-100 (Lantus®, Basaglar®)
    • Insulin glargine U-300 (Toujeo®)
    • Insulin degludec U-100/U-200 (Tresiba®)
    • Humalog® mix 75/25
    • Humalog® mix 50/50
    • Novolog® mix 70/30

    Asthma inhalers include but are not limited to the following list:

    • Albuterol (ProAir®, Ventolin®)
    • Levalbuterol (Xopenex®)
    • Fluticasone (Flovent®)
    • Budesonide (Pulmicort®)
    • Mometasone (Asmanex®)
    • Beclomethasone (QVAR®)
    • Fluticasone and salmeterol (Advair Diskus®)
    • Budesonide and formoterol (Symbicort®)
    • Mometasone and formoterol (Dulera®)
    • Fluticasone and vilanterol (Breo Ellipta®)
    • Salmeterol (Serevent Diskus®)
    • EpiPen® and EpiPen Jr®
    • SYMJEPI® pre-filled epinephrine syringe
    • Generic epinephrine auto-injector

    No, your rank of the waitlist is determined by the date and time your application was complete. Applications are approved from the waitlist on a first-come-first-served basis as funding becomes available.

    Yes. All information you provide is held in the strictest confidence. Only authorized employees and official representatives of a program or agency providing services have access to your information. Federal confidentiality rules apply to your application and documents.

    If your information has changed – you will need to contact the MedAssist Team. You must notify us if any of the following information has changed:

    Information changed